Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients

被引:9
|
作者
Morimoto, Akira [1 ]
Kobayashi, Ryoji [2 ]
Maeda, Miho [3 ]
Asami, Keiko [4 ]
Bessho, Fumio [5 ]
Imashuku, Shinsaku [6 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan
[3] Nippon Med Coll, Dept Pediat, Tokyo 113, Japan
[4] Niigata Canc Ctr, Div Pediat, Niigata, Japan
[5] Kyorin Univ, Sch Med, Dept Pediat, Tokyo, Japan
[6] Takasago Seibu Hosp, Div Pediat, Takasago, Hyogo, Japan
关键词
D O I
10.1002/pbc.21315
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:931 / 932
页数:2
相关论文
共 50 条
  • [1] Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients - Response
    Pollono, Daniel
    Rey, Guadalupe
    Latella, Antonio
    Rosso, Diego
    Chantada, Guillermo
    Braier, Jorge
    PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 932 - 932
  • [2] REACTIVATION AND SEQUELAE IN MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS AT A SINGLE INSTITUTION
    Braier, Jorge
    Rosso, Diego
    Chantada, Guillermo
    Latella, Antonio
    Balancini, Blanca
    Bernaldez, Patricia
    Vaiani, Elisa
    Goldberg, Julio
    PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 691 - 691
  • [3] Reactivation and risk of sequelae in Langerhans cell histiocytosis
    Pollono, Daniel
    Rey, Guadalupe
    Latella, Antonio
    Rosso, Diego
    Chantada, Guillermo
    Braier, Jorge
    PEDIATRIC BLOOD & CANCER, 2007, 48 (07) : 696 - 699
  • [4] Langerhans Cell Histiocytosis in adults with Multi-system Involvement
    Mikhaimer, Nadia C.
    Egberts, Friederike
    Hauschild, Axel
    Schwarz, Thomas
    Kaehler, Katharina C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 679 - 679
  • [5] Langerhans cell histiocytosis presenting as a multi-system disorder in an infant
    Hu, Sheng
    Wang, Wenging
    Wang, Chen
    Ma, Rui
    Xiao, Zhaoyang
    Dong, Hailong
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (06) : 709 - 712
  • [6] Successful Vemurafenib Re-Challenge at Disease Reactivation in Refractory Multi-System Langerhans Cell Histiocytosis
    Soh, S. Y.
    Htet, L. L.
    Lian, D.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S403 - S404
  • [7] Impact of reactivation on the long-term outcome of multi-system Langerhans cell histiocytosis (LCH) patients: Analysis of JLSG-96 protocol study
    Morimoto, Akira
    Ikushima, Satoshi
    Kinugawa, Naoko
    Ishii, Eiichi
    Kohdera, Urara
    Sako, Masahiro
    Fujimoto, Junichiro
    Bessho, Fumio
    Horibe, Keizo
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    PEDIATRIC BLOOD & CANCER, 2007, 48 (07) : 758 - 759
  • [8] Remission of Congenital Multi-system Type Langerhans Cell Histiocytosis with Chemotherapy
    Tamefusa, Kosuke
    Ishida, Hisashi
    Washio, Kana
    Ishida, Toshiaki
    Morita, Hirosuke
    Shimada, Akira
    ACTA MEDICA OKAYAMA, 2019, 73 (01) : 61 - 65
  • [9] MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS PRESENTS AS BLUEBERRY MUFFIN RASH
    Fabrizio, V.
    Menghani, H.
    Velez, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 550 - 550
  • [10] DABRAFENIB FOR RESISTANT BRAF MUTATED MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Hays, Julia Allyson
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S19 - S20